Nissay Asset Management’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.14M | Buy |
20,886
+309
| +2% | +$131K | 0.03% | 286 |
|
|
2026
Q1 | $9.74M | Sell |
20,577
-101
| -0.5% | -$50.8K | 0.05% | 221 |
|
|
2025
Q4 | $9.65M | Sell |
20,678
-1,835
| -8% | -$852K | 0.05% | 228 |
|
|
2025
Q3 | $9.6M | Sell |
22,513
-297
| -1% | -$115K | 0.05% | 214 |
|
|
2025
Q2 | $8.74M | Sell |
22,810
-666
| -3% | -$240K | 0.05% | 233 |
|
|
2025
Q1 | $8.11M | Sell |
23,476
-137
| -0.6% | -$44.1K | 0.05% | 238 |
|
|
2024
Q4 | $7.14M | Sell |
23,613
-418
| -2% | -$146K | 0.04% | 258 |
|
|
2024
Q3 | $9.77M | Sell |
24,031
-221
| -0.9% | -$80.9K | 0.06% | 209 |
|
|
2024
Q2 | $7.79M | Buy |
24,252
+280
| +1% | +$91K | 0.05% | 227 |
|
|
2024
Q1 | $8M | Buy |
23,972
+61
| +0.3% | +$18.6K | 0.06% | 209 |
|
|
2023
Q4 | $6.47M | Sell |
23,911
-912
| -4% | -$225K | 0.05% | 211 |
|
|
2023
Q3 | $6.11M | Buy |
24,823
+833
| +3% | +$228K | 0.05% | 202 |
|
|
2023
Q2 | $7.28M | Sell |
23,990
-585
| -2% | -$163K | 0.06% | 183 |
|
|
2023
Q1 | $6.48M | Sell |
24,575
-2,666
| -10% | -$677K | 0.06% | 188 |
|
|
2022
Q4 | $6.54M | Sell |
27,241
-971
| -3% | -$217K | 0.06% | 191 |
|
|
2022
Q3 | $5.18M | Buy |
28,212
+305
| +1% | +$60.8K | 0.05% | 211 |
|
|
2022
Q2 | $4.69M | Sell |
27,907
-1,506
| -5% | -$324K | 0.05% | 227 |
|
|
2022
Q1 | $7.37M | Sell |
29,413
-104
| -0.4% | -$26.1K | 0.06% | 183 |
|
|
2021
Q4 | $7.58M | Sell |
29,517
-747
| -2% | -$183K | 0.06% | 194 |
|
|
2021
Q3 | $7.35M | Buy |
30,264
+811
| +3% | +$198K | 0.06% | 180 |
|
|
2021
Q2 | $6.09M | Buy |
29,453
+2,486
| +9% | +$507K | 0.05% | 206 |
|
|
2021
Q1 | $5.08M | Sell |
26,967
-664
| -2% | -$117K | 0.05% | 216 |
|
|
2020
Q4 | $4.54M | Sell |
27,631
-47
| -0.2% | -$6.87K | 0.07% | 213 |
|
|
2020
Q3 | $3.45M | Sell |
27,678
-5,696
| -17% | -$705K | 0.06% | 241 |
|
|
2020
Q2 | $3.24M | Buy |
33,374
+1,775
| +6% | +$185K | 0.06% | 274 |
|
|
2020
Q1 | $2.84M | Buy |
31,599
+1,441
| +5% | +$187K | 0.07% | 254 |
|
|
2019
Q4 | $4.46M | Sell |
30,158
-1,713
| -5% | -$230K | 0.1% | 224 |
|
|
2019
Q3 | $3.84M | Buy |
31,871
+1,212
| +4% | +$157K | 0.09% | 242 |
|
|
2019
Q2 | $4.14M | Sell |
30,659
-3,297
| -10% | -$417K | 0.1% | 225 |
|
|
2019
Q1 | $4.43M | Sell |
33,956
-1,563
| -4% | -$210K | 0.12% | 204 |
|
|
2018
Q4 | $4.42M | Sell |
35,519
-437
| -1% | -$58.7K | 0.13% | 191 |
|
|
2018
Q3 | $5M | Sell |
35,956
-1,165
| -3% | -$145K | 0.13% | 182 |
|
|
2018
Q2 | $3.81M | Sell |
37,121
-404
| -1% | -$40.9K | 0.11% | 225 |
|
|
2018
Q1 | $3.64M | Sell |
37,525
-3,452
| -8% | -$335K | 0.11% | 224 |
|
|
2017
Q4 | $3.6M | Buy |
+40,977
| New | +$3.29M | 0.11% | 242 |
|
Other funds holding HCA
Nissay Asset Management's HCA Position: Q2 2026 in Review
Nissay Asset Management increased its HCA Healthcare (HCA) stake by 1.5% in Q2 2026, buying an estimated $131K and bringing the position to 20,886 shares worth $8.14M. The position accounts for 0.03% of the portfolio, ranked #286.
Nissay Asset Management first reported a position in HCA in Q4 2017 and has held it in 35 quarters since. The position peaked at $9.77M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Nissay Asset Management held 20,886 shares of HCA Healthcare worth $8.14M as of Q2 2026.
- Nissay Asset Management bought 309 HCA Healthcare shares in Q2 2026, an estimated $131K.
- HCA Healthcare made up 0.03% of Nissay Asset Management's portfolio in Q2 2026, its #286 holding.
- Nissay Asset Management first reported a position in HCA Healthcare in Q4 2017 and has held it in 35 quarters since.
- Nissay Asset Management's HCA Healthcare position peaked at $9.77M in Q3 2024.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Nissay Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.